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TNF-R2 expression in acquired middle ear cholesteatoma
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Acquired middle ear cholesteatoma is a disease which promotes bone erosion resulting in 
potentially serious complications. The tumor necrosis factor alpha (TNF-α) is present in cholesteatoma 
and it is related to bone erosion, as shown by different authors. To understand the aggressiveness 
characteristics of cholesteatoma is necessary, however, to better address the presence and distribution 
of their receptors. 
Objective: To evaluate the expression of type 2 TNF-α receptor (TNF-R2) in fragments of 
cholesteatoma and correlate it to the degree of inflammation present. 
Material and methods: observational cross-sectional study, which analyzed 33 fragments of 
cholesteatomas through histological analysis and immunohistochemistry (using as primary antibody 
to TNF-R2 LabVision ® brand). The evaluation was performed by means of a qualitative and semi-
quantitative agreement with the observed intensity. For statistical analysis we used the Fisher exact 
test and Spearman´s correlation coefficient (considered statistically significant when p ≤ 0.05). 
Results: The expression of TNF-R2 was present in all fragments, however a statistical analysis showed 
no correlation or association between inflammation and the expression of TNF-R2. 
Conclusions: TNF-R2 is present in cholesteatoma of the middle ear, however, its expression is not 
directly related to the degree of inflammation observed in patients with this disease.
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INTRODUCTION
The middle ear acquired cholesteatoma was first 
described by, Curveilhier, in 18291, and it is characterized 
by tympanic cavity invasion by a keratinized squamous 
epithelium, which is different from the columnar pseu-
dostratified ciliated epithelium, with goblet cells present 
near the auditory tube or the simple, cubic or columnar 
squamous cell epithelium - of the remaining middle ear2. 
Histologically, cholesteatomas may be broken down into 
matrix (epithelium) and peri-matrix (underlying connec-
tive tissue)3.
The cholesteatoma matrix has four distinct layers: 
basal, spinous, granulous and strata cornea, as well as the 
thin skin. The peri-matrix is characterized by the presence 
of a loose connective tissue made up of collagen and elas-
tic fibers, fibroblasts and inflammatory cells4. Histological 
analysis of the cholesteatoma matrix may show different 
patterns: atrophy, acanthosis, basal layer hyperplasia 
and epithelial cones. It is common to find many of these 
patterns occurring at the same time in the same patient2.
Because of its capacity to cause bone erosion, 
present in 80% of the cases5, the cholesteatoma is res-
ponsible for extracranial and intracranial complications. 
These complications, when present, carry a high rate of 
morbidity and mortality6. Hence the relevance of studying 
the mechanisms through which acquired middle ear cho-
lesteatomas cause bone erosion.
The early 90’s saw the publication of the first papers 
suggesting that TNF-α could be an important cytokine 
involved in the bone destruction process7,8. The cytoki-
nes released in the inflammatory process present in the 
peri-matrix would be the ones responsible for the bone 
destruction seen in cholesteatomas9. Among these, TNF-α 
stands out as one of the main cytokines involved in this 
process, working together with the Receptor Activator 
Nuclear Kappa B Ligant (RANKL) and interleukins 1 and 
6, to cause bone destruction and remodeling10. Therefore, 
we stress the importance of studying the expression of 
TNF-R2 and its association with the inflammatory process.
TNF-R2 has been described in different organs, e.g. 
the kidney, brain and ovary, being always associated with 
the inflammatory process because of the activation of the 
Kappa B nuclear factor (NF-kB)11-13. Notwithstanding, there 
is still no description of TNF-R in cholesteatomas.
The two TNF-α receptors have similar activities. 
They are involved in the inflammatory process, being as-
sociated with bone erosion and they can trigger apoptosis 
(programmed cell death), the latter is especially associated 
with the TNF-R2. However, the mechanism responsible 
for establishing which effect will prevail is still not totally 
clear13.
OBJECTIVES
The goal of the present study was to assess the 
expression of the type-2 tumor necrosis factor alpha 
receptor (TNF-R2), by means of using immunohistoche-
mistry techniques in cholesteatoma fragments acquired 
from the middle ear and correlate them with the degree 
of inflammation present.
MATERIALS AND METHODS 
This is a cross-sectional, observational study, ap-
proved by the Ethics Committee of the Medical School 
of Santa Casa de Misericórdia de São Paulo, where it was 
carried out. The material encompassed 68 cholesteatoma 
fragments taken from 68 patients submitted to ear surgery 
in order to remove the acquired cholesteatoma from the 
middle ear. The surgeries were done in the Department 
of Otorhinolaryngology of this Institution from August 
2007 through March 2009. The disease diagnosis was 
based on the clinical history and physical exam of the 
patients. The surgical procedures were done by different 
otorhinolaryngologists.
From this study we extracted those fragments which 
did not have an epithelium (matrix), visible upon light 
microscopy, dyed by hematoxylin-eosin (HE), and 35 
fragments were excluded. This way, the total number of 
fragments used in this study was 33.
After removing the cholesteatoma fragments, the 
material was fixed in 10% formaldehyde and processed by 
conventional histology techniques, with paraffin inclusion. 
For histology purposes, we considered the following pat-
terns: atrophy (matrix with a thickness of a maximum of 
four layers of keratinocytes), acanthosis (matrix thickness 
increase in lieu of the spinous layer), basal layer hyperpla-
sia (increase in the number of basal keratinocyte layers), 
epithelial cone formation (matrix invaginations to inside 
the peri-matrix) and inflammatory process present in the 
peri-matrix. The assessment was carried out in qualitative 
(present or absent) and semi-quantitative fashions, grade 
varying between 0 and 3 according to the intensity obser-
ved (absent = 0; weak = 1; moderate = 2 and severe = 3).
For immunohistochemistry we used the primary 
TNF-R2 polyclonal primary antibody synthetized from 
rats (Labvision®, USA), in the title of 1:100. The secondary 
antibody used was the Max Polymer Detection System 
(New Kit Link, Novocastra®, UK).
The immunohistochemical evaluation was carried 
out in a quantitative form (present or absent) and semi-
quantitative, graded between 0 and 3 according to the 
intensity of the color observed: absent = 0; weak = 1(Figure 
1); moderate = 2 (Figure 2) and severe = 3 (Figure 3).
The slides with cholesteatoma fragments were 
analyzed under a light microscope model Axioscope 40 
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the histopathological and immunohistochemical variables.
To study the association among the qualitative va-
riables we used the Fisher’s exact test. In order to check 
for the correlation among the quantitative variables we 
used the Spearman Coefficient.
All the tests were carried out in a bicaudal way and 
the significance level adopted was 5%.
RESULTS
We studied 33 cholesteatoma fragments from 33 
patients submitted to ear surgery, 17 of them (51.5%) were 
men and 16 (48.5%) women. Minimum age was seven ye-
ars, and the eldest patient was 70 years old, with mean age 
of 30 years, median of 31 years and standard deviation of 
16.4. Of the 33 patients included in the study, two (6.1%) 
did not know how long it was between symptom onset 
and admission at the Department of Otorhinolaryngology 
for surgery. Of the 31 patients who reported it, 13 said 
they had had the disease for less than five years (41.9%), 
seven reported between six and ten years (22.6%), nine 
mentioned a time span between 11 and 20 years (29%) 
and, only two patients reported having had the disease 
for over 20 years (6.5%). Time between symptom onset 
and admission to surgery at the Department of otorhinola-
ryngology varied between one and 60 years, with a mean 
of 11.5, median of eight years and standard deviation of 
11.6 years.
In regards of the ear affected by the disease, four pa-
tients (12.1%) had chronic cholesteatomatous otitis media 
in both ears, and 29 (87.9%) had unilateral involvement; 
15 (45.5%) in the right ear and 14 (42.4%) in their left ears.
As far as clinical symptoms reported by the patients 
upon admission goes, 31 (93.9%) reported otorrhea, 30 
(90.9%) reported hypoacusis and 27 (81.8%), reported 
Figure 1. Microphotography from a cholesteatoma fragment, in which 
we see a weak reaction against the TNF-R2 receptor in the cytoplasm 
of the matrix keratinocytes (IHQ X400).
Figure 2. Microphotography of the cholesteatoma fragment, in which 
we notice moderate reaction against the TNF-R2 receptor in the cyto-
plasm of the matrix keratinocytes (IHQ X400).
(Carl Zeiss - Brazil), with a 10X eye piece and 10X, 20X 
and 40X magnification lens for histological evaluation 
and also for immunohistochemistry. All the slides were 
assessed by three independent observers, in a blinded 
way. The microscope was coupled to an Axiocam MRc 5 
(Zeiss) camera in order to obtain the digital images of the 
material, using the Axiovision 4.8 software.
After data collection we setup a computerized 
database which was submitted to statistical analysis, with 
the help of the Statistical Package for the Social Sciences 
(SPSS) version 13.0 software.
We carried out a descriptive analysis, calculating 
minimum and maximum values, mean, median and stan-
dard deviation for the age variable and calculations of 
the absolute and relative frequencies for gender and for 
Figure 3. Microphotography of the cholesteatoma fragment where we 
see a severe reaction against the TNF-R2 antibody in the cytoplasm of 
matrix keratinocytes (IHQ X400).
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dizziness spells.
Ossicular chain involvement was reported in 28 
patients (84.8%), who had erosion in one of the ossicles 
and, in five (15.2%) the ossicular chain was not seen in-
volved during intraoperative assessment. Considering the 
ossicle involved, 23 patients (69.7%) had malleus erosion, 
23 (69.7%) had incus erosion, and 18 (54.5%) had stapes 
erosion.
Besides ossicular chain involvement, we noticed 
the presence of erosion in the semicircular canal, facial 
nerve exposure and also dura mater exposure. There was 
semicircular canal erosion in three patients (9.1%), facial 
nerve exposure in six (18.2%) and dura mater exposure 
in five (15.2%).
Histological assessment found more than one his-
topathological pattern (atrophy, acanthosis, basal layer 
hyperplasia and epithelial cones) simultaneously, in most 
of the cholesteatoma fragments analyzed.
Because of the lack of a peri-matrix in one of the 
33 fragments investigated, it was not possible to assess the 
intensity of the inflammation in that case. Of the 32 remai-
ning cases, inflammation was absent in one (3.1%), weak 
in 14 (43.8%), moderate in 13 (40.6%) and severe in four 
(12.5%) (Figure 4). The inflammatory infiltrate was mostly 
lymphoplasmacytic with areas of neovascularization.
significant association between the degree of inflammation 
present in the middle ear acquired cholesteatoma and 
the presence of TNF-R2 (p= 0.589). We also did not see 
positive and statistically significant correlation using the 
Spearman’s correlation coefficient (p= 0.155).
DISCUSSION
The middle ear acquired cholesteatoma is a disease 
characterized by tympanic cavity invasion by an epithelium 
(matrix) which is different from the one usually found in 
the middle ear. Histologically, this epithelium is similar 
no normal skin3.
Histological analysis also showed that the matrix 
may present with different histological patterns, such as 
atrophy, acanthosis, basal layer hyperplasia and epithelial 
cones. These patterns frequently coexist in the same frag-
ment, as shown in the present study. These histological 
findings are in agreement with what has been published 
in the literature2,4.
The evaluation of the peri-matrix from the choles-
teatoma fragments reported inflammatory process present 
in 96.9% of the cases, in different severities. This fact is in 
agreement with reports from Pereira4 (2001) and Alves et 
al.2 (2008), who noticed an inflammatory infiltrate in the 
peri-matrix in 90.9% and 96.0%, respectively. These results 
match the clinical history of middle ear acquired choleste-
atomas, because it is a disease which, most of the times, 
happens together with an intense infectious inflammatory 
process. This inflammatory and infectious reaction is as-
sociated with bone erosion and the complications caused 
by this disease14. Nonetheless, the statistical analysis did 
not show any correlation or association between TNF-R2 
expression and the inflammatory process severity.
Cholesteatomas usually cause ossicular chain ero-
sion. In the present study, during surgery, we noticed that 
Figure 4. Inflammatory process severity analysis.
Upon immunohistochemical evaluation we ob-
served a reaction from the anti-TNF-R2 antibody in the 
matrix cells in all the cholesteatoma fragments analyzed. 
This reaction was considered weak in 10 cases (30.3%), 
moderate in 18 (54.5%) and severe in five (15.2%) (Figure 
5). Besides the cytoplasmic reaction, we also observed 
reactions in almost all the keratinocyte nuclei from the 
matrix of the analyzed fragments, and also in the nuclei 
of inflammatory cells present in the peri-matrix.
The statistical analysis did not show statistically 
Figure 5. ITNR-R2 distribution in the cholesteatoma fragments 
analyzed.
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the ossicular chain was eroded 84.4% of the patients. These 
data corroborate literature data, which report ossicular 
chain erosion on 91.5% of the patients14.
In the present study, the most affected ossicle was 
the incus, especially its long apophysis, and the malleus, 
both in 23 patients (69.7%). Stapes erosion happened in 18 
patients (54.5%). These findings differ from the ones from 
Tos15 and Dornelles et al.16 who reported incus erosion 
as the most frequent, followed by the stapes and, later, 
the malleus.
The middle ear acquired cholesteatoma is a disease 
which courses with an intensive infectious and inflam-
matory process. Such condition induces the release of 
different substances (cytokines and growth factors) whi-
ch act together in synergism, resulting in the aggressive 
cholesteatoma characteristics9. Among these substances 
we stress the interleukins 1, 6 and 8, TGF-α, TGF-β, EGF, 
KGF and, especially, the TNF-α, considered one of the 
main cytokines involved in inflammatory and immune 
processes17.
There are two receptors for TNF-α, the TNF-R1 and 
the TNF-R2. The role of each one of the TNF-α receptors 
is still unclear13.
The goal of the present study was to investigate 
TNF-R2 expression by means of immunohistochemical 
techniques in middle ear acquired cholesteatoma frag-
ments and correlate them to the degree of inflammation 
seen upon histology.
In this study we assessed TNF-R2 expression by 
means of immunohistochemical techniques in middle ear 
acquired cholesteatoma fragments. TNF-R2 reaction was 
cytoplasmic and happened in all the keratinocytes of the 
matrix from analyzed fragments. There was also reaction 
in some peri-matrix inflammatory cells (lymphocytes and 
plasmocytes). Besides TNF-R2 expression, inflammation 
was also present.
We carried out a statistical analysis in order to check 
whether or not there was any association or correlation 
between TNF-R2 expression and the degree of inflam-
mation. However, in our study we did not see TNF-R2 
involvement in the cholesteatoma’s inflammation. In 
other words, the TNF-α receptor is present in the middle 
ear acquired cholesteatoma; nonetheless, its expression 
(number of receptors) is not associated with the degree of 
inflammation seen. Notwithstanding, we still need further 
studies, with larger cholesteatoma samples, in order to 
obtain a more reliable statistical analysis.
In the present study, besides the cytoplasmic re-
action (pattern) arising from the connection between the 
TNF-α and the TNF-R2, we also detected a significant 
nuclear expression in all the slides assessed, in epithelial 
cells of the matrix and in some cells of the peri-matrix 
inflammatory infiltrate (lymphocytes and plasmocytes). 
This reaction may indicate a crossed reaction with some 
cell nucleus proteins; however, this still needs further 
clarification in future studies.
CONCLUSIONS
1) TNF-R2 is present in acquired middle ear cho-
lesteatoma matrixes.
2) It was not possible to correlate TNF-R2 expression 
with the degree of inflammation present in the acquired 
middle ear cholesteatoma.
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